First Command Advisory Services’s Vertex Pharmaceuticals VRTX Stock Holding History

First Command Advisory Services's VRTX Position: Q2 2026 in Review

First Command Advisory Services reduced its Vertex Pharmaceuticals (VRTX) stake by 83% in Q2 2026, selling an estimated $29.7K and leaving 14 shares worth $6.95K. The position accounts for ﹤0.01% of the portfolio, ranked #824.

First Command Advisory Services first reported a position in VRTX in Q1 2023 and has held it in 13 quarters since. The position peaked at $308K in Q1 2024. 1,747 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

• First Command Advisory Services held 14 shares of Vertex Pharmaceuticals worth $6.95K as of Q2 2026.
• First Command Advisory Services sold 67 Vertex Pharmaceuticals shares in Q2 2026, an estimated $29.7K.
• Vertex Pharmaceuticals made up ﹤0.01% of First Command Advisory Services's portfolio in Q2 2026, its #824 holding.
• First Command Advisory Services first reported a position in Vertex Pharmaceuticals in Q1 2023 and has held it in 13 quarters since.
• First Command Advisory Services's Vertex Pharmaceuticals position peaked at $308K in Q1 2024.
• 1,747 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on First Command Advisory Services's 13F filing for Q2 2026, filed 10 Aug 2026.